Panacea Biotec Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue increased from ₹115.72 Cr to ₹147.35 Cr in recent quarters, showing strong growth.
Net Profit improved to ₹4.71 Cr in the latest quarter, reversing previous losses.
Expenses have decreased, allowing for better profitability despite fluctuating revenues.

NEGATIVES

The recent quarter saw a net profit of only ₹4.71 Cr, down from ₹10.98 Cr in Q1.
Profit margins remain inconsistent, with significant losses in prior quarters.
Operating profit has not stabilized, indicating potential volatility in earnings.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Jun 25
Revenue	129.19	143.02	150.50	136.46	115.72	147.35	163.49	166.70
Expenses	149.98	156.80	160.61	152.13	139.31	150.01	165.50	177.13
Operating Profit	-20.79	-13.78	-10.11	-15.67	-23.59	-2.66	-2.01	-10.43
Other Income	6.08	3.23	5.68	10.81	3.80	4.65	3.62	5.67
Interest	1	0.91	0.85	0.82	0.87	0.98	0.99	0.86
Depreciation	9.48	9.31	9.11	8.81	8.73	8.68	8.98	8.39
Profit Before Tax	13.03	-7.78	-1.65	-2.12	-17.05	4.76	4.38	6.56
Tax	2.05	0.51	0.55	-0.13	-1.17	0.05	-0.06	2.60
Net Profit	10.98	-8.29	-2.20	-1.99	-15.88	4.71	4.44	3.96
Eps in Rs	1.79	-1.35	-0.37	-0.23	-2.59	0.77	0.74	0.66